T86.19: Other complication of kidney transplant
T86.19, other complication of kidney transplant, is listed as a covered diagnosis in 12 Medicare billing and coding articles that apply to 109 HCPCS Level II codes, including J1569 (Injection, immune globulin, (gammagard liquid/gammagard…), J1561 (Injection, immune globulin, (gamunex-c/gammaked)…), J1459 (Injection, immune globulin (privigen), intravenous…). 20 of these codes have a 2026 DMEPOS fee schedule amount; K0730 pays $245.69 (RR) depending on the state. The articles come from 5 Medicare contractors. A listed diagnosis supports medical necessity only; coverage still depends on the LCD's criteria and on documentation in the medical record.
HCPCS Level II codes with T86.19 as a covered diagnosis
| Code | Description | Medicare coverage | DMEPOS fee 2026 (state range) | Articles listing it |
|---|---|---|---|---|
| J1569 | Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg | Special coverage instructions apply | — | 5 |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Special coverage instructions apply | — | 5 |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | Carrier judgment | — | 5 |
| J1557 | Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg | Carrier judgment | — | 5 |
| J1556 | Injection, immune globulin (bivigam), 500 mg | Carrier judgment | — | 5 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Carrier judgment | — | 5 |
| J1566 | Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg | Special coverage instructions apply | — | 5 |
| J1552 | Injection, immune globulin (alyglo), 500 mg | Carrier judgment | — | 4 |
| J1554 | Injection, immune globulin (asceniv), 500 mg | Carrier judgment | — | 4 |
| J1599 | Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg | Carrier judgment | — | 4 |
| J1299 | Injection, eculizumab, 2 mg | Carrier judgment | — | 1 |
| Q5151 | Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg | Carrier judgment | — | 1 |
| Q5152 | Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg | Carrier judgment | — | 1 |
| J1576 | Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg | Special coverage instructions apply | — | 3 |
| J1577 | Injection, immune globulin (qivigy), 100 mg | Carrier judgment | — | 3 |
| J1572 | Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg | Special coverage instructions apply | — | 2 |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | Special coverage instructions apply | — | 1 |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | Special coverage instructions apply | — | 1 |
| J7510 | Prednisolone oral, per 5 mg | Special coverage instructions apply | — | 1 |
| Q0510 | Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant | Special coverage instructions apply | — | 1 |
| J7599 | Immunosuppressive drug, not otherwise classified | Special coverage instructions apply | — | 1 |
| J1553 | Injection, immune globulin (yimmugo), 100 mg | Carrier judgment | — | 1 |
| J9312 | Injection, rituximab, 10 mg | Special coverage instructions apply | — | 2 |
| Q5123 | Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Carrier judgment | — | 2 |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | Carrier judgment | — | 2 |
84 more codes are listed. See every code with payment by region in Caduvo.
Medicare policy articles listing T86.19
- A54548: Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI®-eculizumab-aagh, and BKEMV™-eculizumab-aeeb (Wellpoint Federal (MAC - Part A, MAC - Part B); 3 Level II codes)
- A52474: Immunosuppressive Drugs - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC); 5 Level II codes). LCD with the same title: L33824
- A57187: Billing and Coding: Immune Globulin Intravenous (IVIg) (Noridian Healthcare Solutions, LLC (MAC - Part A, MAC - Part B); 13 Level II codes). LCD with the same title: L34314
- A56779: Billing and Coding: Intravenous Immune Globulin (CGS Administrators, LLC (MAC - Part A, MAC - Part B); 9 Level II codes). LCD with the same title: L33610, L35891
- A56718: Billing and Coding: Intravenous Immunoglobulin (IVIG) (Palmetto GBA (MAC - Part A, MAC - Part B); 13 Level II codes). LCD with the same title: L34580
- A52466: Nebulizers - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC); 53 Level II codes). LCD with the same title: L33370
- A59105: Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG) (Wellpoint Federal (MAC - Part A, MAC - Part B); 11 Level II codes). LCD with the same title: L39314
- A55639: Billing and Coding: Chemotherapy Agents for Non-Oncologic Conditions (WPS Insurance Corporation (MAC - Part A, MAC - Part B); 6 Level II codes)
- A59101: Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars (Wellpoint Federal (MAC - Part A, MAC - Part B); 4 Level II codes). LCD with the same title: L38920, L39297
- A57554: Billing and Coding: Immune Globulins (WPS Insurance Corporation (MAC - Part A, MAC - Part B); 20 Level II codes). LCD with the same title: L34771
- A56747: Billing and Coding: Magnetic Resonance Angiography (MRA) (Wellpoint Federal (MAC - Part A, MAC - Part B); 18 Level II codes). LCD with the same title: L33633, L34372, L34865
- A56775: Billing and Coding: Magnetic Resonance Angiography (Palmetto GBA (MAC - Part A, MAC - Part B); 18 Level II codes). LCD with the same title: L34424
A diagnosis listed as covered in a billing and coding article supports medical necessity for the article's codes; it does not guarantee payment. Coverage depends on the LCD's criteria, the contractor's jurisdiction and documentation in the medical record.
Other T86 diagnoses (Complications of transplanted organs and tissue)
- T86.10 — Unspecified complication of kidney transplant
- T86.11 — Kidney transplant rejection
- T86.12 — Kidney transplant failure
- T86.13 — Kidney transplant infection
- T86.00 — Unspecified complication of bone marrow transplant
- T86.01 — Bone marrow transplant rejection
- T86.02 — Bone marrow transplant failure
- T86.03 — Bone marrow transplant infection
- T86.09 — Other complications of bone marrow transplant
- T86.20 — Unspecified complication of heart transplant
- T86.21 — Heart transplant rejection
- T86.22 — Heart transplant failure
- T86.23 — Heart transplant infection
- T86.290 — Cardiac allograft vasculopathy
- T86.298 — Other complications of heart transplant
- T86.30 — Unspecified complication of heart-lung transplant
- T86.31 — Heart-lung transplant rejection
- T86.32 — Heart-lung transplant failure
- T86.33 — Heart-lung transplant infection
- T86.39 — Other complications of heart-lung transplant
- T86.41 — Liver transplant rejection
- T86.42 — Liver transplant failure
- T86.43 — Liver transplant infection
- T86.49 — Other complications of liver transplant
- T86.5 — Complications of stem cell transplant
- T86.810 — Lung transplant rejection
- T86.811 — Lung transplant failure
- T86.812 — Lung transplant infection
- T86.818 — Other complications of lung transplant
- T86.830 — Bone graft rejection
Frequently asked questions
Does Medicare cover T86.19 (Other complication of kidney transplant)?
Medicare covers items and services, not diagnoses. 12 Medicare billing and coding articles list T86.19 as a covered diagnosis for 109 HCPCS Level II codes: the diagnosis can support medical necessity for those codes, but payment still depends on the LCD's coverage criteria and the medical record.
Which HCPCS codes can be billed with ICD-10 T86.19?
The Level II codes from the policies most specific to this diagnosis are J1569 (Injection, immune globulin, (gammagard liquid/gammagard…, 5 articles); J1561 (Injection, immune globulin, (gamunex-c/gammaked)…, 5 articles); J1459 (Injection, immune globulin (privigen), intravenous…, 5 articles); J1557 (Injection, immune globulin, (gammaplex), intravenous…, 5 articles); J1556 (Injection, immune globulin (bivigam), 500 mg, 5 articles). Code choice depends on the item supplied; check each code's descriptor.
What does Medicare pay for equipment billed with T86.19?
Under the 2026 DMEPOS fee schedule (non-rural state fees): K0730 $245.69 (RR); E1372 $136.61 to $208.94 (NU); A7017 $130.82 to $194.58 (NU); E0580 $164.65 to $182.27 (NU). Medicare pays 80% of the allowed amount after the Part B deductible.
Which Medicare policy articles list T86.19?
A54548 (Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI®-eculizumab-aagh, and BKEMV™-eculizumab-aeeb); A52474 (Immunosuppressive Drugs - Policy Article); A57187 (Billing and Coding: Immune Globulin Intravenous (IVIg)), and 9 more articles.
What is ICD-10-CM code T86.19?
T86.19 is the ICD-10-CM code for other complication of kidney transplant, in category T86 (Complications of transplanted organs and tissue), chapter 19: Injury, poisoning and other consequences of external causes.
Next steps
- Run a reimbursement report for a device billed under J1569
- Watch J1569 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1569
Sources: CMS Medicare Coverage Database billing and coding articles (covered ICD-10 code lists and HCPCS links); ICD-10-CM FY2026; CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule 2026 (non-rural state fees). Not billing or legal advice.
Chapter 19: Injury, poisoning and other consequences of external causes · All diagnoses · HCPCS lookup